Home Newsfeeds Barrington Research Downgrades CuriosityStream to Market Perform

Barrington Research Downgrades CuriosityStream to Market Perform

Barrington Research analyst James Goss downgrades CuriosityStream (NASDAQ:CURI) from Outperform to Market Perform.

byBenzinga Newsdesk

August 16, 2022

1 minute read

Barrington Research analyst James Goss downgrades CuriosityStream (NASDAQ:CURI) from Outperform to Market Perform.

Trulieve Launches Khalifa Kush In Florida With Wiz Khalifa, Will Donate To Hurricane Ian Victims

By Joana Scopel

October 3, 6:17 PM

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) announced the official launch of Khalifa Kush premium medical cannabis products in select Florida retail locations this Saturday, October 8.

CSE:TRUL

Analyst Ratings

The Latest Analyst Ratings For Boyd Gaming

By Benzinga Insights

January 26, 3:00 PM

Throughout the last three months, 4 analysts have evaluated Boyd Gaming (NYSE:BYD), offering a diverse set of opinions…

BYD

FDA
News

Blueprint Medicines Submits Supplemental New Drug Application To FDA For AYVAKIT For Treatment Of Indolent Systemic Mastocytosis

By Michael Horton

November 22, 5:39 PM

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the submission of a supplemental new drug application to the U.S. Food and Drug Administration (FDA) for AYVAKIT® (avapritinib) for the treatment of adults with indolent systemic mastocytosis (SM).

BPMC

EXCLUSIVE: Promising Use Cases For AI And Blockchain With SingularityNET CEO Ben Goertzel

By Murtuza Merchant

June 20, 9:18 AM

Ben Goertzel, CEO of SingularityNET on Tuesday shed light on the promising use cases for AI and blockchain technology in the near future, asserting that the most significant impact will be felt on finance, healthcare and entertainment s

$AGIX

Barrington Research Downgrades CuriosityStream to Market Perform

Related Posts

Trulieve Launches Khalifa Kush In Florida With Wiz Khalifa, Will Donate To Hurricane Ian Victims

The Latest Analyst Ratings For Boyd Gaming

Blueprint Medicines Submits Supplemental New Drug Application To FDA For AYVAKIT For Treatment Of Indolent Systemic Mastocytosis

EXCLUSIVE: Promising Use Cases For AI And Blockchain With SingularityNET CEO Ben Goertzel